Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 434

Results For "HR"

5878 News Found

Olympus announces exclusive U.S. co-marketing agreement with Bracco Diagnostics
Medical Device | May 20, 2022

Olympus announces exclusive U.S. co-marketing agreement with Bracco Diagnostics

The partnership will further strengthen Olympus leadership in the diagnosis and staging of liver disease


Propanc Biopharma undertaking PRP manufacturing & development for human use
Biotech | May 20, 2022

Propanc Biopharma undertaking PRP manufacturing & development for human use

PRP is a mixture of two proenzymes, trypsinogen and chymotrypsinogen from bovine pancreas administered by intravenous injection


Driving sustainable, enterprise-wide performance acceleration
Opinion | May 19, 2022

Driving sustainable, enterprise-wide performance acceleration

Leading pharma companies are achieving rapid, large-scale performance improvements using a multifaceted approach that realizes short-term gains & builds long-term capabilities at the same time


Grand Opening of Kodiak Sciences’ bioconjugation facility
Biotech | May 19, 2022

Grand Opening of Kodiak Sciences’ bioconjugation facility

Purpose-built bioconjugation facility in Lonza’s Ibex Dedicate Biopark in Visp, Switzerland to support the potential commercial launch of Kodiak's lead product candidate KSI-301 for high-prevalence retinal diseases


IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine
Biotech | May 19, 2022

IAVI and Moderna launch first-in-Africa clinical trial of mRNA HIV vaccine

Phase I trial in Rwanda and South Africa aims to evaluate mRNA HIV vaccine antigen for safety and immunogenicity and strengthen regional scientific capacity


Don’t be left short-changed post approval – plan in change orders early for accelerated pathways: Stephanie Gaulding
News | May 19, 2022

Don’t be left short-changed post approval – plan in change orders early for accelerated pathways: Stephanie Gaulding

A post approval change order is often necessary, but innovators should plan and prepare for this pre-approval. Planning alongside outsourcing partners will help ensure that only a small-scale study is needed—not a new full clinical study


Biocon Biologics and Viatris launch Abevmy in Canada
Drug Approval | May 19, 2022

Biocon Biologics and Viatris launch Abevmy in Canada

Abevmy follows the launch of the company’s two oncology biosimilars in Canada, Ogivri (bTrastuzumab) in 2019 – the first Trastuzumab approved in the country – and Fulphila (bPegfilgrastim), which was launched in 2020


Janssen’s icare4u to assist people living with skin, joint and digestive disorders
Healthcare | May 19, 2022

Janssen’s icare4u to assist people living with skin, joint and digestive disorders

The icare4u program features a dedicated website, with comprehensive information about the diseases, videos with medical experts, and a social media community for patients and caregivers on Facebook and YouTube


CDSCO approves Jardiance for heart failure with preserved ejection fraction
Drug Approval | May 19, 2022

CDSCO approves Jardiance for heart failure with preserved ejection fraction

With the approval from the Central Drugs Standard Control Organisation (CDSCO), Jardiance is now the first approved therapy to improve outcomes for the full spectrum of heart failure regardless of ejection fraction


Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics
News | May 19, 2022

Synexa Life Sciences acquires Finnish CRO Syrinx Bioanalytics

Expansion of leading biomarker and bioanalysis company enhances bioanalytical solutions for targeted radiopharmaceuticals